98%
921
2 minutes
20
Background And Purpose: To assess the neural substrates underlying topographical disorientation (TD) in patients affected by mild cognitive impairment (MCI), forty-one patients diagnosed with MCI and 24 healthy control individuals were recruited.
Methods: TD was assessed clinically in all participants. Neurological and neuropsychological evaluations and a volumetric-head magnetic resonance imaging scan were performed in each participant. Voxel-based morphometry was used to compare patterns of gray-matter atrophy between patients with and without TD, and a group of normal controls.
Results: We found TD in 17 out of the 41 MCI patients (41.4%). The functional abilities were significantly impaired in MCI patients with TD compared to in MCI patients without TD. Voxel-based morphometry analyses showed that the presence of TD in MCI patients is associated with loss of gray matter in the medial temporal regions, including the hippocampus and parahippocampal cortex, the fusiform gyrus, the inferior occipital gyrus, the amygdala, and the cerebellum.
Conclusions: The findings found in this study represent the first evidence that the presence of TD in patients with MCI is associated with loss of gray matter in those brain regions that have been documented to be responsible for orientation in both neuropsychological and neuroimaging studies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024525 | PMC |
http://dx.doi.org/10.3988/jcn.2010.6.4.204 | DOI Listing |
Alzheimer's disease (AD) has become a great concern for society in general and clinicians specifically because of its high morbidity, relative lack of awareness of its characteristics, and low diagnosis and treatment rates. Worldwide, there is a lack of effective treatments for slowing the progression of AD in clinical practice. Thus, the management of patients in the preclinical phase of AD (PPAD) has been identified to be highly important for addressing this concern.
View Article and Find Full Text PDFCureus
August 2025
Internal Medicine, Nishtar Medical University, Multan, PAK.
This systematic review explores the application of advanced neuroimaging techniques, diffusion tensor imaging (DTI) and functional MRI (fMRI), in identifying early neural alterations in patients with cognitive impairment and neurodegenerative disorders. By synthesizing data from nine recent clinical studies, the review highlights the integration of structural and functional imaging in detecting subtle brain connectivity changes associated with conditions such as mild cognitive impairment (MCI), Parkinson's disease, Alzheimer's disease, and subjective cognitive decline (SCD). The findings suggest that specific imaging parameters, including fractional anisotropy and task-based functional deactivation, correlate strongly with cognitive outcomes and therapeutic responses.
View Article and Find Full Text PDFPrehosp Disaster Med
September 2025
CACI, Inc, Falls Church, VirginiaUSA.
Introduction: Targeted identification, effective triage, and rapid hemorrhage control are essential for optimal outcomes of mass-casualty incidents (MCIs). An important aspect of Emergency Medical Service (EMS) care is field triage, but this skill is difficult to teach, assess, and research.
Study Objective: This study assessed triage efficacy and hemorrhage control of emergency responders from different professions who used the Sort, Assess, Life-Saving Treatment (SALT) triage algorithm in a virtual reality (VR) simulation of a terrorist subway bombing.
Epilepsy Behav
September 2025
Department of Neurology, Washington University School of Medicine, 660 Euclid Ave., Campus Box 8111, St. Louis, MO, USA; Institute of Public Health, Washington University in St. Louis, 600 S Taylor Ave, St. Louis, MO 63110, USA.
Objectives: Insufficient data exist for driving risk for people with epilepsy (PWE). This longitudinal, retrospective case-control study examines the differences in driving behaviors among older adults with/without epilepsy history using a novel naturalistic driving datalogger.
Methodology: Eligible participants were cognitively normal ([CDR] = 0) or had mild cognitive impairment (MCI) ([CDR] = 0.
Eur J Nucl Med Mol Imaging
September 2025
Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Chiba-shi, Chiba, 263-8555, Japan.
Purpose: Astrocyte reactivation can be assessed using positron emission tomography (PET) ligands targeting monoamine oxidase B (MAO-B). C-SL25.1188 binds reversibly to MAO-B, allowing precise density measurements, but requires invasive arterial sampling.
View Article and Find Full Text PDF